Fingerprint
Dive into the research topics of 'A phase II trial of safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in healthy infants'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically